In Early Trial, Promising Results for Moderna’s Combo COVID-Flu Vaccine
THURSDAY, Oct. 5, 2023 (HealthDay News) — Moderna Inc. announced Wednesday that it has seen positive early results with a new vaccine that would guard against four strains of flu plus COVID-19. In interim findings from a Phase 1/2 trial, the vaccine showed both a strong immune response compared toContinue Reading